Finance Watch: Biotech Stocks Stabilize At The End Of A Rocky Week
Values Still Down Sharply Year-To-Date
Public Company Edition: Valuations have fallen enough in 2022 to lead some companies to wind down operations, but a recent uptick opened a window for a few offerings. Chinook raised $105m in a follow-on offering, while Flagship led a $79.2m registered direct offering for Evelo.
